Kraig Biocraft Laboratories, Inc. was pleased to announce this morning that during the months of May, June and July the scientific team achieved its previously announced goal to significantly ramp up the number of genetic insertions performed. The team’s initial goal was to double the number of DNA construct insertions performed in May. However, the actual number of insertions performed greatly exceeded that goal and the increase was sustained in June and July as well.

“Over the last ninety days, Dr. Fraser’s team has performed tens of thousands of DNA construct insertions. This increase in laboratory productivity greatly exceeded management’s expectations for the period,” stated CEO Kim K. Thompson. “This dramatic increase in productivity is an indication of the dedication and enthusiasm of the scientists. We know that each insertion has the potential to create a new recombinant fiber with commercial applications.”

Let us

Kraig Biocraft Laboratories, Inc. announced this morning that Dr. Fraser’s team has “made significant progress on developing enzymes and strategies for conducting site specific genetic recombination in silkworm.”

“In the Company’s view, the development of this particular gene splicing technology is the key to unlocking the tremendous commercial potential of spider silks and other recombinant polymers,” stated Kraig’s CEO, Kim K. Thompson. “Dr. Fraser’s report of this news from the laboratory is the culmination of years of scientific effort. It is a huge milestone on the path to commercialization,” continued Thompson.

“We believe that we are the only people who have this capability at this time.” Dr. Fraser added.

Dr. Fraser’s team of research scientists, working within University of Notre Dame laboratories, has made several significant advancements over the last four or five months. This most recent announcement follows shortly after the company’s report that

Today, Kraig Biocraft announced that Dr. Fraser’s research team has successfully made 5,000 genetic transfers in a single week using the newly designed DNA insertion packets. The Company anticipates having preliminary test results back on these five thousand genetic insertions within the next 45 days.

“Every DNA packet insertion has the potential to create a new recombinant fiber with commercial applications. The achievement of 5,000 such insertions in a single week is something that the Company would not have dreamed of in 2008,” CEO Kim K. Thompson enthusiastically stated. “At the same time, Dr. Fraser is reporting a large increase in the team’s observation of the occurrence of transient expression shortly after the gene transfers are preformed.” The research team believes this is a strong indication of the viability of the genetic transfers.

“More importantly,” added Mr. Thompson, “the research team is now performing these gene transfers

Kraig Biocraft Laboratories has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including spider silk, which may have numerous commercial and consumer applications.

The company possesses coded gene sequences that relate to spider silk production and is currently working on injecting this material into silkworm eggs. The team at the University of Notre Dame, led by Dr. Fraser, has recently been strengthened to further refine the microinjection process as well as increase the number of microinjections preformed.

In most recent news, the company excitedly announced that the scientific team has achieved the activation of fluorescent marker gene sequences that were incorporated into spider silk DNA packets by the researchers. The team has successfully inserted the DNA packets into silkworms, which are now visibly emitting florescence. This achievement is